Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 30,911 shares of the firm’s stock in a transaction on Monday, April 3rd. The stock was sold at an average price of $18.00, for a total transaction of $556,398.00. Following the completion of the sale, the chief financial officer now owns 147,778 shares in […]